We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALO icon
2201
Talos Energy
TALO
$2.36B
$696K ﹤0.01%
34,237
+2,713
+9% +$58.8K
ALTA
2202
DELISTED
Altabancorp
ALTA
$696K ﹤0.01%
24,596
+1,858
+8% +$52.8K
AKBA icon
2203
Akebia Therapeutics
AKBA
$249M
$695K ﹤0.01%
177,258
+16,059
+10% +$68.8K
GHL
2204
DELISTED
Greenhill & Co., Inc.
GHL
$693K ﹤0.01%
52,799
-897
-2% -$12.8K
OLBK
2205
DELISTED
Old Line Bancshares, Inc.
OLBK
$693K ﹤0.01%
23,896
+1,976
+9% +$53.9K
CARB
2206
DELISTED
Carbonite Inc
CARB
$690K ﹤0.01%
44,553
-250
-0.6% -$4.45K
VRS
2207
DELISTED
Verso Corporation
VRS
$688K ﹤0.01%
55,604
+4,464
+9% +$61K
TRC icon
2208
Tejon Ranch
TRC
$448M
$686K ﹤0.01%
40,395
+2,892
+8% +$50.4K
VKTX icon
2209
Viking Therapeutics
VKTX
$3.87B
$685K ﹤0.01%
99,622
+7,803
+8% +$58K
OMN
2210
DELISTED
OMNOVA Solutions Inc.
OMN
$685K ﹤0.01%
67,997
-450
-0.7% -$4.46K
AXDX
2211
DELISTED
Accelerate Diagnostics
AXDX
$680K ﹤0.01%
3,665
+43
+1% +$8.31K
AAOI icon
2212
Applied Optoelectronics
AAOI
$10.3B
$679K ﹤0.01%
60,473
+2,950
+5% +$29.6K
AROW icon
2213
Arrow Financial
AROW
$659M
$675K ﹤0.01%
22,757
+1,921
+9% +$55.4K
VIRT icon
2214
Virtu Financial
VIRT
$4.92B
$675K ﹤0.01%
41,288
-480
-1% -$9.6K
AUD
2215
DELISTED
Audacy, Inc.
AUD
$674K ﹤0.01%
201,913
+16,561
+9% +$74.3K
UNT
2216
DELISTED
UNIT Corporation
UNT
$674K ﹤0.01%
199,274
+20,060
+11% +$98.7K
SHYF
2217
DELISTED
The Shyft Group
SHYF
$673K ﹤0.01%
49,080
+977
+2% +$11.9K
ELF icon
2218
e.l.f. Beauty
ELF
$5.49B
$671K ﹤0.01%
38,323
+2,787
+8% +$46.5K
COWN
2219
DELISTED
Cowen Inc. Class A Common Stock
COWN
$668K ﹤0.01%
43,396
+3,487
+9% +$56.6K
CPRX
2220
DELISTED
Catalyst Pharmaceutical
CPRX
$666K ﹤0.01%
125,392
-790
-0.6% -$4.21K
RC
2221
Ready Capital
RC
$276M
$664K ﹤0.01%
41,707
+4,489
+12% +$68.1K
WTI icon
2222
W&T Offshore
WTI
$492M
$662K ﹤0.01%
151,580
+13,061
+9% +$59.7K
TFSL icon
2223
TFS Financial
TFSL
$5.04B
$661K ﹤0.01%
36,660
-50
-0.1% -$896
TCX icon
2224
Tucows
TCX
$156M
$660K ﹤0.01%
12,177
-80
-0.7% -$4.17K
GSHD icon
2225
Goosehead Insurance
GSHD
$2.37B
$657K ﹤0.01%
13,308
-90
-0.7% -$4.14K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.